Hem › Pulmonell hypertoni › Illinois › Chicago
Kliniska studier för Pulmonell hypertoni i Chicago, IL
5 studier för Pulmonell hypertoni söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RekryterarFas 2
- Clinical Research Site, Chicago
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Rekryterar
- Northwestern University, Chicago
- University of Illinois Health, Chicago
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
RekryterarFas 3
- Northwestern University, Chicago
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekryterarObservationsstudie
- Northwestern University, Chicago
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekryterar
- University of Chicago, Chicago
Pulmonell hypertoni-studier i andra städer
- Philadelphia, PA10 studier
- Aurora, CO9 studier
- Phoenix, AZ9 studier
- Cincinnati, OH8 studier
- Indianapolis, IN8 studier
- New York City, NY8 studier
- Boston, MA8 studier
- Kansas City, KS8 studier
- Charleston, SC7 studier
- Rochester, MN7 studier
- Salt Lake City, UT7 studier
- Houston, TX7 studier
Andra studier i Chicago
- Icke-småcellig lungcancer61 studier
- Bröstcancer59 studier
- Cancer (alla typer)51 studier
- Metastaserande cancer45 studier
- Prostatacancer45 studier
- Lungcancer41 studier
- Övervikt41 studier
- Äggstockscancer36 studier
- Kolorektal cancer34 studier
- Stroke34 studier
- Hjärtsvikt31 studier
- Övervikt29 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.